Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune ...
Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a major target of cancer immunotherapy. Unfortunately, drugs that target it do ...
This new article publication from Acta Pharmaceutica Sinica B, discusses the deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for ...
A team of researchers from the Institute of Biophysics of the Future at MIPT has developed a fully genetically encoded two-stage drug delivery system that allows antitumor drug to be directed directly ...
Clinical pharmacist Dr. Christina Madison joins WIRED to answer the internet's burning questions about pharmacology and pharmaceuticals. Does a medication “go bad” after its expiration date? How do ...
For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has approved a new pain medication that could change how we manage acute pain. The drug is called suzetrigine and ...
Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its antibody-drug conjugate Dato-DXd marketed ...
1 College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China 2 Department of Breast and Thyroid Surgery, Affiliated Hospital of Shandong ...
Impact of a Multidisciplinary Supportive Care Model Using Distress Screening at an Asian Ambulatory Cancer Center: A Cluster Randomized Controlled Trial The AMBORA Center conducted over 800 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results